Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05010590
PHASE4
Anabolic Therapy in Postmenopausal Osteoporosis
Sponsor: Massachusetts General Hospital
View on ClinicalTrials.gov
Summary
In this research study we want to learn more about the effect of two different FDA-approved medications in the treatment of osteoporosis.
Key Details
Gender
FEMALE
Age Range
45 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2022-03-24
Completion Date
2027-11-01
Last Updated
2025-09-26
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Romosozumab
Monthly romosozumab
DRUG
Denosumab
Every 6 months denosumab
Locations (1)
Massachusetts General Hospital
Boston, Massachusetts, United States